Jade Biosciences, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Jade Biosciences, Inc. reported Cash And Cash Equivalents At Carrying Value of $88.44 million for the year ending 2025.

  • Jade Biosciences, Inc. showed an increase of +27.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Jade Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 6, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Jade Biosciences, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 1,833.9%.
  • Historical annual values: Fiscal year 2025: $88.44 million | Fiscal year 2024: $69.39 million | Fiscal year 2023: $23.49 million | Fiscal year 2022: $22.40 million | Fiscal year 2021: $54.20 million | Fiscal year 2020: $4.57 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: